title: CCK satiety is differentially mediated by high- and low-affinity CCK receptors in mice and rats.
abstract: Cholecystokinin-JMV-180 (JMV-180) is an analogue of cholecystokinin C-terminal octapeptide (CCK-8), which has been shown to be an agonist at the proposed CCK pancreatic high-affinity site and a functional antagonist at the pancreatic low-affinity site in rats and to have agonist activity at both high- and low-affinity sites in the mouse. In this study we used JMV-180 to evaluate the potential participation of these two CCK-A sites in the satiety effect of CCK-8 in rats and mice. When tested at doses that ranged from 0.01 to 9.2 mumol/kg, JMV-180 did not reliably affect food intake of solid or liquid test diets in rats. When combined with CCK-8 (3.2 or 8.5 nmol/kg) JMV-180 dose dependently reversed the satiety effect of CCK-8. In contrast to these results in the rat, both JMV-180 (3.7-14.8 mumol/kg) and CCK-8 (1.7-6.8 nmol/kg) dose dependently reduced the intake of 20% sucrose in mice. Both CCK-8- and JMV-180-induced suppression of food intake were attenuated by the CCK-A antagonist MK-329 (24.8 nmol/kg). The results of these studies suggest that agonist activity at sites pharmacologically similar to the CCK pancreatic high-affinity site is not sufficient for expression of CCK satiety, whereas agonist activity at low-affinity-like sites is necessary to reduce food intake. Thus the anorexic activity of CCK appears to be mediated through an interaction with a receptor site pharmacologically similar to the pancreatic low-affinity CCK receptor site.
authors.affiliation: Department of Neurobiology, Hoffmann-LaRoche, Nutley, New Jersey 07110.
authors.forename: S C
authors.initials: SC
authors.lastname: Weatherford
authors.forename: W B
authors.initials: WB
authors.lastname: Laughton
authors.forename: J
authors.initials: J
authors.lastname: Salabarria
authors.forename: W
authors.initials: W
authors.lastname: Danho
authors.forename: J W
authors.initials: JW
authors.lastname: Tilley
authors.forename: L A
authors.initials: LA
authors.lastname: Netterville
authors.forename: G J
authors.initials: GJ
authors.lastname: Schwartz
authors.forename: T H
authors.initials: TH
authors.lastname: Moran
mesh_terms: D000818:Animals; D001570:Benzodiazepinones / Q000494:pharmacology; D002766:Cholecystokinin / Q000037:antagonists & inhibitors; D020109:Devazepide; D004305:Dose-Response Relationship, Drug; D004435:Eating / Q000187:drug effects; D005947:Glucose; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D051381:Rats; D017207:Rats, Sprague-Dawley; D011949:Receptors, Cholecystokinin / Q000502:physiology*; D012528:Satiety Response; D012844:Sincalide / Q000031:analogs & derivatives / Q000494:pharmacology*; D013395:Sucrose
chemical_list: D001570:Benzodiazepinones; D011949:Receptors, Cholecystokinin; C058451:JMV 180; D013395:Sucrose; D002766:Cholecystokinin; D005947:Glucose; D020109:Devazepide; D012844:Sincalide